Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM)

CUSIP: 14216R101

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
41,966,083
Total 13F shares
5,567,108
Share change
+5,566,902
Total reported value
$17,259,637
Put/Call ratio
14%
Price per share
$3.10
Number of holders
34
Value change
+$17,258,816
Number of buys
33

Quarterly Holders Quick Answers

What is CUSIP 14216R101?
CUSIP 14216R101 identifies CARM - Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) as of Q1 2023

As of 31 Mar 2023, Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,567,108 shares. The largest 10 holders included TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, TPG GP A, LLC, VANGUARD GROUP INC, BML Capital Management, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Deuterium Capital Management, LLC, WITTENBERG INVESTMENT MANAGEMENT, INC., and MILLENNIUM MANAGEMENT LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.